|
|
|
|
||
        |  |
 |
|
|
 |
|
 |
||||||||
|
||||||||||
|
|
|
|
|||||||
|
||||||||||
|
Preface • EDITORIAL Roger Adan SummaryPlus | Full Text + Links | PDF (82 K) | |||
|
Thyroid hormones in the pathogenesis and treatment of obesity • ARTICLE Marcin Krotkiewski SummaryPlus | Full Text + Links | PDF (233 K) | |||
|
 3-Adrenoceptor agonists: potential, pitfalls and progress • ARTICLEJonathan R. S. Arch SummaryPlus | Full Text + Links | PDF (194 K) | |||
|
Orlistat: its current status as an anti-obesity drug • ARTICLE Anne Ballinger and Steven R. Peikin SummaryPlus | Full Text + Links | PDF (135 K) | |||
|
The discovery and status of sibutramine as an anti-obesity drug • ARTICLE Carla A. Luque and Jose A. Rey SummaryPlus | Full Text + Links | PDF (128 K) | |||
|
Leptin and the treatment of obesity: its current status • ARTICLE Daniel W. Lee, Matthew C. Leinung, Marina Rozhavskaya-Arena and Patricia Grasso SummaryPlus | Full Text + Links | PDF (142 K) | |||
|
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity • ARTICLE Douglas J. MacNeil, Andrew D. Howard, Xiaoming Guan, Tung M. Fong, Ravi P. Nargund, Maria A. Bednarek, Mark T. Goulet, David H. Weinberg, Alison M. Strack, Donald J. Marsh et al. SummaryPlus | Full Text + Links | PDF (457 K) | |||
|
Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides • ARTICLE Philip J. Larsen, Niels Vrang, Mads Tang-Christensen, Per Bo Jensen, Anders Hay-Schmidt, John Rømer, Lotte Bjerre-Knudsen and Peter Kristensen SummaryPlus | Full Text + Links | PDF (353 K) | |||
|
Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status • ARTICLE Eric Parker, Margaret Van Heek and Andrew Stamford SummaryPlus | Full Text + Links | PDF (208 K) | |||
|
The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance • ARTICLE Denis Richard, Qin Lin and Elena Timofeeva SummaryPlus | Full Text + Links | PDF (126 K) | |||
|
Orexins and the treatment of obesity • ARTICLE Darren Smart, Andrea C. Haynes, Gareth Williams and Jonathan R. S. Arch SummaryPlus | Full Text + Links | PDF (210 K) | |||
|
ACRP30, a new hormone controlling fat and glucose metabolism • ARTICLE Tsu-Shuen Tsao, Harvey F. Lodish and Joachim Fruebis SummaryPlus | Full Text + Links | PDF (171 K) | |||
|
Peroxisome proliferator activated receptors and obesity • ARTICLE Sander Kersten SummaryPlus | Full Text + Links | PDF (274 K) | |||
|
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity • ARTICLE Giampiero Muccioli, Matthias Tschöp, Mauro Papotti, Romano Deghenghi, Mark Heiman and Ezio Ghigo SummaryPlus | Full Text + Links | PDF (362 K) | |||
|
Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction? • ARTICLE Andrew L. Gundlach SummaryPlus | Full Text + Links | PDF (399 K) | |||
|
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives • ARTICLE Juris J. Meier, Baptist Gallwitz, Wolfgang E. Schmidt and Michael A. Nauck SummaryPlus | Full Text + Links | PDF (347 K) | |||
|
Bombesin and its family of peptides: prospects for the treatment of obesity • ARTICLE Kazuyuki Yamada, Etsuko Wada, Yuko Santo-Yamada and Keiji Wada SummaryPlus | Full Text + Links | PDF (146 K) | |||
|
Author index • MISCELLANEOUS PDF (212 K) | |||
|
Keyword index • MISCELLANEOUS PDF (615 K) | |||
|
|
|
|
|
|
| Copyright © 2004 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V. |
